Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Assay Monitors Cardiomyopathy in Chagas Disease

By LabMedica International staff writers
Posted on 08 Mar 2011
A serum assay for a protein in the blood has been used to monitor damage to the heart in patients with chronic Chagas disease. More...


A highly sensitive assay for measuring the protein biomarker, cardiac troponin T (cTnT), has been used to assess heart injury in patients suffering from the tropical disease caused by the blood-borne protozoan parasite, Trypanosoma cruzi.

In an international study carried out at the Charité University Hospital, (Berlin, Germany), serum cTnT was measured in 26 healthy subjects and in 179 patients with chronic Chagas disease, of whom 86 were asymptomatic, 71 were suffering from cardiomyopathy with or without megacolon, and 22 were suffering from megacolon exclusively. Megacolon is an abnormal dilation of the colon is often accompanied by a paralysis of the peristaltic movements of the bowel.

For serum cTnT measurement, the conventional, fourth-generation assay and the highly sensitive assay provided by Roche Diagnostics GmbH (Mannheim, Germany), were performed using Roche's Elecsys-2010 chemistry analyzer. Serum cTnT was significantly higher in patients with cardiomyopathy with or without megacolon than in healthy subjects, asymptomatic subjects, and patients with megacolon, and the cTnT value was correlated with the severity of the cardiomyopathy. The lower limit of detection for the highly sensitive assay, was 3 ng/L, and was best at distinguishing patients with, and without, heart injury. C-reactive protein and interleukin 6 were found to parallel cTnT changes in both the different Chagas groups and the cardiomyopathy groups separated by disease severity.

The authors commented that the introduction of cardiac troponin immunoassays with improved sensitivity enables the mirroring of minor, but distinct, cardiac troponin elevations with diagnostic and prognostic effect in pathophysiological conditions of the heart, such as inflammation and cardiomyopathy. With the highly sensitive cTnT assay, a diagnostic tool is now available that supplies data usable in chronic Chagas disease for diagnosis, prognosis, and monitoring of cardiomyopathy. The cTnT measurement could, in their view, supplement electrocardiography, echocardiography, and radiological imaging in patients with chronic Chagas disease, and in special circumstances, be applied before these other diagnostic tools. The study was published in February 2011, in the Archives of Pathology and Laboratory Medicine.

Related Links:

Charité University Hospital
Roche Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.